Rivaroxaban (Xarelto) Gains First FDA Approval for DVT Prevention
Rivaroxaban(Xarelto, Janssen) received FDA approval today for the prevention of deep vein thrombosis
Read more on Forbes

Once-Daily Anticoagulant Xarelto Approved By FDA For DVT Prevention
Blood thinner (anticoagulant) Xarelto (rivaroxaban tablets) has been approved by the FDA (Food and Drug Administration) for the prevention of DVT (deep vein thrombosis) in patients who had knee or hip replacement surgery. The tablets are taken once daily. According to Xarelto makers, Janssen Pharmaceuticals, Inc., about 80,000 patients in the USA undergo hip or knee replacement surgery every …
Read more on Medical News Today

100 Questions & Answers About Hip Replacement
Endorsed by the American Academy of Orthopedic Surgeons! Whether you or a relative have recently had a hip replacement or are con…

Will It Hurt Doctor? – Hip Replacement

Getting Hip: Recovery From A Total Hip Replacement
GETTING HIP is a personal account of one woman’s recovery from a total hip replacement. From the painful arthritic deterioration o…

Incoming search terms:

• rivaroxaban bracelet